Brazil’s CADE approves Amil-Dasa joint venture after three-month review
The Brazilian competition authority’s investigative arm has approved a joint venture between healthcare companies Amil and Dasa, which will form a new company called Ímpar Serviços Hospitalares, to be equally managed...To view the full article, register now.
Already a subscriber? Click here to view full article